Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02297230
Title Locally Advanced Breast Cancer: Individualized Treatment Based On Tumor Molecular Characteristics
Recruitment Terminated
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors New York University School of Medicine
Indications

Her2-receptor positive breast cancer

Therapies

Capecitabine

Paclitaxel

Paclitaxel + Trastuzumab

Age Groups: adult
Covered Countries USA


No variant requirements are available.